Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oxidative stress enzymes and pathways constitute a sophisticated biological network dedicated to the regulation of reactive oxygen species (ROS) and the maintenance of cellular redox balance (Frontiers in Oncology, 2023). This system encompasses a variety of enzymes, including ROS-generating species like NADPH oxidase (NOX) and myeloperoxidase (MPO), as well as antioxidant defense enzymes such as superoxide dismutase (SOD), catalase, and glutathione peroxidase (MDPI Biomolecules, 2024; NIH/PMC, 2024). Central to this network is the Nrf2-Keap1 signaling pathway, which acts as a master regulator of the antioxidant response by inducing the transcription of cytoprotective genes (NIH/PMC, 2024). Chronic imbalance in these pathways leads to oxidative stress, a condition implicated in the pathogenesis of numerous diseases, including neurodegeneration, cardiovascular disorders, and cancer (Frontiers in Oncology, 2023; NIH/PMC, 2023). Therapeutic interventions often focus on either inhibiting pro-oxidant enzymes or activating endogenous antioxidant defenses to mitigate oxidative damage (MDPI Biomolecules, 2024; MDPI Antioxidants, 2024). However, because ROS also function as critical signaling molecules in physiological processes like cell proliferation and immune defense, pharmacological modulation must be carefully tuned to avoid disrupting essential cellular functions (NIH/PMC, 2024; MDPI Antioxidants, 2024). Drugs targeting these pathways include Nrf2 activators like dimethyl fumarate and enzyme inhibitors like verdiperstat (NIH/PMC, 2024). The complexity of these interactions necessitates a multi-target or highly specific approach to achieve therapeutic efficacy without significant toxicity (MDPI Biomolecules, 2024).
Activation of the Nrf2-Keap1 pathway to induce antioxidant gene expression, inhibition of pro-oxidant enzymes such as NADPH oxidase (NOX) and myeloperoxidase (MPO), and direct scavenging of reactive oxygen species (ROS).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxidative stress enzymes and pathways.